S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:MDXG

MiMedx Group Stock Forecast, Price & News

$8.77
-0.36 (-3.94 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.68
Now: $8.77
$9.35
50-Day Range
$7.83
MA: $9.35
$10.31
52-Week Range
$2.95
Now: $8.77
$10.51
Volume477,430 shs
Average Volume632,080 shs
Market Capitalization$973.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.71
MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The company's proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, arterial ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill, a connective tissue matrix derived from placental disc, umbilical cord, and amnion/chorion tissues. Its products have applications in the areas of wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. The company sells its products through direct sales force, independent sales agents, and third party representatives, as well as independent distributors. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MDXG
CUSIPN/A
CIKN/A
Phone770 651 9100
Employees696

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$299.26 million
Book Value$0.31 per share

Profitability

Net Income$-25,580,000.00

Miscellaneous

Market Cap$973.86 million
Next Earnings Date3/16/2021 (Estimated)
OptionableOptionable
$8.77
-0.36 (-3.94 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDXG News and Ratings via Email

Sign-up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MiMedx Group (NASDAQ:MDXG) Frequently Asked Questions

How has MiMedx Group's stock been impacted by COVID-19?

MiMedx Group's stock was trading at $5.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MDXG stock has increased by 60.9% and is now trading at $8.77.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than MiMedx Group?

Wall Street analysts have given MiMedx Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MiMedx Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is MiMedx Group's next earnings date?

MiMedx Group is scheduled to release its next quarterly earnings announcement on Tuesday, March 16th 2021.
View our earnings forecast for MiMedx Group
.

How were MiMedx Group's earnings last quarter?

MiMedx Group, Inc. (NASDAQ:MDXG) released its quarterly earnings results on Wednesday, November, 4th. The company reported ($0.48) earnings per share (EPS) for the quarter. The business had revenue of $64.30 million for the quarter. MiMedx Group had a negative return on equity of 404.08% and a negative net margin of 37.28%.
View MiMedx Group's earnings history
.

Who are some of MiMedx Group's key competitors?

Who are MiMedx Group's key executives?

MiMedx Group's management team includes the following people:
  • Mr. Timothy R. Wright, CEO & Director (Age 62, Pay $1.69M)
  • Mr. Peter Martin Carlson CPA, Chief Financial Officer (Age 56, Pay $581.54k)
  • Mr. Scott M. Turner, Sr. VP of Operations & Procurement (Age 55, Pay $493.98k)
  • Mr. William L. Phelan, Sr. VP & Chief Accounting Officer
  • Mr. John J. Howarth, Sr. VP of Investor Relations
  • Mr. Mark P. Graves, Sr. VP & Chief Compliance Officer (Age 55)
  • Mr. William F. Hulse IV, Gen. Counsel & Sec. (Age 46)
  • Hilary Dixon, VP of Investor Relations & Corp. Communications
  • Dr. David H. Mason Jr., Chief Medical Officer (Age 73)
  • Mr. Stan Micek, Sr. VP of Bus. Devel. & Portfolio Management

What is MiMedx Group's stock symbol?

MiMedx Group trades on the NASDAQ under the ticker symbol "MDXG."

Who are MiMedx Group's major shareholders?

MiMedx Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pegasus Asset Management Inc. (0.15%).
View institutional ownership trends for MiMedx Group
.

Which institutional investors are buying MiMedx Group stock?

MDXG stock was acquired by a variety of institutional investors in the last quarter, including Pegasus Asset Management Inc..
View insider buying and selling activity for MiMedx Group
or or view top insider-buying stocks.

How do I buy shares of MiMedx Group?

Shares of MDXG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MiMedx Group's stock price today?

One share of MDXG stock can currently be purchased for approximately $8.77.

How big of a company is MiMedx Group?

MiMedx Group has a market capitalization of $973.86 million and generates $299.26 million in revenue each year. MiMedx Group employs 696 workers across the globe.

What is MiMedx Group's official website?

The official website for MiMedx Group is www.mimedx.com.

How can I contact MiMedx Group?

MiMedx Group's mailing address is 1775 W OAK COMMONS COURT NE, MARIETTA GA, 30062. The company can be reached via phone at 770 651 9100 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.